Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
160.13
+0.27 (0.17%)
Nov 1, 2024, 4:00 PM EDT - Market closed
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Oct 2, 2022 | Jul 3, 2022 | Apr 3, 2022 | Jan 2, 2022 | Oct 3, 2021 | Jul 4, 2021 | Apr 4, 2021 | Jan 3, 2021 | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 29, 2019 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 30, 2018 | Sep 30, 2018 | Jul 1, 2018 | Apr 1, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical Revenue | 56.35B | 55.67B | 54.91B | 54.76B | 54.20B | 53.52B | 53.11B | - | - | - | - | - | - | - | |||||||||||||
| Pharmaceutical Revenue Growth | 3.97% | 4.01% | 3.39% | 4.18% | 1.09% | 0.44% | 1.03% | - | - | - | - | - | - | - | |||||||||||||
| Medtech Revenue | 31.34B | 30.91B | 30.74B | 30.40B | 29.50B | 28.83B | 27.94B | - | - | - | - | - | - | - | |||||||||||||
| Medtech Revenue Growth | 6.23% | 7.22% | 10.03% | 10.84% | 7.24% | 5.32% | 1.77% | - | - | - | - | - | - | - | |||||||||||||
| Consumer Health Revenue | - | - | - | - | 15.43B | 15.22B | 14.95B | - | - | - | - | - | - | - | |||||||||||||
| Consumer Health Revenue Growth | - | - | - | - | 3.31% | 2.41% | 0.91% | - | - | - | - | - | - | - |
Revenue by Geography
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Oct 2, 2022 | Jul 3, 2022 | Apr 3, 2022 | Jan 2, 2022 | Oct 3, 2021 | Jul 4, 2021 | Apr 4, 2021 | Jan 3, 2021 | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 29, 2019 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 30, 2018 | Sep 30, 2018 | Jul 1, 2018 | Apr 1, 2018 | Dec 31, 2017 | Oct 1, 2017 | Jul 2, 2017 | Apr 2, 2017 | Jan 1, 2017 | Oct 2, 2016 | Jul 3, 2016 | Apr 3, 2016 | Jan 3, 2016 | Sep 27, 2015 | Jun 28, 2015 | Mar 29, 2015 | Dec 28, 2014 | Sep 28, 2014 | Jun 29, 2014 | Mar 30, 2014 | Dec 29, 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| US Revenue | 49.11B | 48.19B | 49.07B | 49.97B | 50.41B | 50.61B | 48.58B | 48.23B | |||||||||||||||||||||||||||||||||||
| US Revenue Growth | -2.58% | -4.78% | 1.00% | 3.61% | 5.60% | 6.64% | 3.02% | 3.04% | |||||||||||||||||||||||||||||||||||
| Europe Revenue | 20.25B | 20.07B | 20.75B | 21.92B | 22.48B | 23.84B | 23.97B | 24.56B | |||||||||||||||||||||||||||||||||||
| Europe Revenue Growth | -9.89% | -15.81% | -13.43% | -10.76% | -8.71% | -1.52% | 1.57% | 11.93% | |||||||||||||||||||||||||||||||||||
| Asia Pacific and Africa Revenue | 13.59B | 13.57B | 14.60B | 15.50B | 16.50B | 17.24B | 17.27B | 17.22B | |||||||||||||||||||||||||||||||||||
| Asia Pacific and Africa Revenue Growth | -17.62% | -21.28% | -15.46% | -9.95% | -4.38% | -0.95% | -0.03% | 1.22% | |||||||||||||||||||||||||||||||||||
| Western Hemisphere Excluding US Revenue | 4.75B | 4.74B | 5.24B | 5.64B | 6.03B | 6.40B | 6.17B | 6.04B | |||||||||||||||||||||||||||||||||||
| Western Hemisphere Excluding US Revenue Growth | -21.35% | -25.87% | -14.97% | -6.66% | -0.71% | 8.31% | 5.44% | 4.23% |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.